No Data
No Data
Anavex Life Sciences to Present at the 45th Annual TD Cowen Health Care Conference
Buy Rating for Anavex Life Sciences Due to Solid Financials and European Market Potential
Anavex Life Sciences Reports Higher Quarterly Loss Amid R&D Focus
Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday?
Earnings Call Summary | Anavex Life Sciences(AVXL.US) Q1 2025 Earnings Conference
Anavex Projects EMA Feedback on Alzheimer's Drug by Year-end 2025